- Peptide drugs have the advantages of significant curative effect, high safety and wide indications.
- chemical synthesis method and gene recombination method have obvious advantages in yield, product purity, preparation speed and other aspects, which are two kinds of polypeptide preparation with high application popularity in the international market at this stage Backup mode.
- There are a large number of pharmaceutical enterprises in China, but limited by technology, process, equipment and other factors, the number of peptide drug manufacturers is small.
Peptide drugs have the advantages of significant curative effect, high safety and wide indications.
With the development of biotechnology and peptide synthesis technology, more and more peptide drugs have been developed and marketed or in clinical trials.
Peptide drugs can be widely used in the treatment of endocrine system, immune system, digestive system, cardiovascular system and other diseases. The development and application of peptide drugs in the world is relatively short, but the market is developing rapidly, which has become a hot spot in the pharmaceutical industry.
The preparation methods of peptide drugs mainly include extraction method, chemical synthesis method, gene recombination method and enzyme degradation method. Among them, the extraction method is extracted from animals and plants, the content of polypeptide is small and the purity is low, enzyme degradation method will get a series of peptides, separation and purification is difficult, these two preparation methods are less used;
chemical synthesis method and gene recombination method have obvious advantages in yield, product purity, preparation speed and other aspects, which are two kinds of polypeptide preparation with high application popularity in the international market at this stage Backup mode.
Peptide drugs have outstanding advantages in efficacy and safety, and the global market is growing rapidly. From 2015 to 2019, the compound annual growth rate of the global peptide drug market is 8.2%; in 2019, the global peptide drug market scale is about 29.4 billion US dollars, with a year-on-year growth of 7.9%;
it is estimated that the global peptide drug market will reach about 31.5 billion US dollars in 2020. Peptide drugs occupy a small proportion in the global pharmaceutical market, but their growth rate is fast, and the market share will continue to rise in the future.
There are a large number of pharmaceutical enterprises in China, but limited by technology, process, equipment and other factors, the number of peptide drug manufacturers is small.
Compared with the overall pharmaceutical market, the competition in the peptide drug market in China is relatively gentle.
In China’s polypeptide drug market, Novartis pharmaceutical, American saisheng, Merck syrano and other foreign enterprises occupy a large market share, but the single enterprise market share is relatively small, and the monopoly pattern has not yet formed.
Domestic enterprises have a large development space. Domestic enterprises represented by Zhonghe pharmaceutical, Hanyu pharmaceutical and Shuangcheng pharmaceutical are developing rapidly and their market share is increasing continuously.
According to the report on in-depth market research and investment strategy recommendations of polypeptide drug industry in 2020-2024 issued by xinsijie Industry Research Center, the compound annual growth rate of China’s polypeptide drug market is 10.7% from 2015 to 2019; in 2019, the market scale of polypeptide drugs in China is 79.5 billion yuan, with a year-on-year growth of 10.4%;
it is estimated that the market scale of polypeptide drugs in China will reach about 87.6 billion yuan in 2020 。 The growth rate of peptide drug market in China is higher than the average growth rate of global market, and the industry has a good development prospect in the future.
New thinking industry analysts said that peptide drugs have outstanding advantages in efficacy, safety, indications and other aspects, and have become a hot spot in the research and development of the global pharmaceutical industry.
With the increasing number of patients with chronic diseases in the world, the demand for peptide drugs is growing faster than the overall growth rate of the pharmaceutical market. Compared with the international market, China’s polypeptide drug market is growing more rapidly.
However, foreign enterprises account for a large share of the market, and domestic enterprises are accelerating their development. With the increasing accumulation of technology and experience, domestic leading peptide drug manufacturers may have the strength to compete with foreign enterprises in the future.
For sale, buy peptides, purchase peptides, and buy peptides online, you can find the Chinese peptide company:
Shengnuo Biotechnology is a high-tech China polypeptide manufacturers,who has over 19 years experience for the biotechnology .Our Products involve peptide raw materials,polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
Our service scope：peptide synthesis、peptide hormones、peptide medicine、beauty peptide、peptide medicine product、peptide technology transfer、peptide technology service、peptide large-scale production、export of peptide
Thymopentin for Injection、 Thymalfasin for Injection 、 Bivalirudin 、Bulk Drug、 Liraglutide ……
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.